Sign in
Active, not recruitingNo phase

Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)

Key facts

Who runs it
Children's Hospital Medical Center, Cincinnati
Where
Ann Arbor, Atlanta, Boston, Los Angeles, New Haven, New Hyde Park, New York, Palo Alto, Philadelphia, Rochester, Salt Lake City, and San Francisco, United StatesSee the 14 sitesAlso in 1 other country, 1 site
Trial code
Status
Active, not recruiting
People taking part
32,000 people, planned
Started
15 Nov 2010
Expected to end
Dec 2032
Type of study
Observational
Record updated
30 January 2026

Who can take part

Age
Up to 99 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Signed consent form

Who cannot take part

  • Isolated patent foramen ovale
  • Isolated prematurity-associated patent ductus arteriosus

Where in United States

Also in 1 other country, 1 site

  • University of Michigan HealthAnn Arbor, United States
  • Children's Healthcare of AtlantaAtlanta, United States
  • Brigham & Women's HospitalBoston, United States
  • Children's Hospital, BostonBoston, United States
  • Children's Hospital Los AngelesLos Angeles, United States
  • Yale UniversityNew Haven, United States
  • Cohen Children's Medical Center New YorkNew Hyde Park, United States
  • Columbia University Medical CenterNew York, United States
  • Mount Sinai School of MedicineNew York, United States
  • Stanford UniversityPalo Alto, United States
  • Children's Hospital PhiladelphiaPhiladelphia, United States
  • University of RochesterRochester, United States
  • University of UtahSalt Lake City, United States
  • University of California San FranciscoSan Francisco, United States

About the trial

What the trial wants to find out

Congenital heart defects (CHD) are the most common major human birth malformation, affecting ~8 per 1,000 live births. CHD are associated with significant morbidity and mortality, and are second only to infectious diseases in contributing to the infant mortality rate. Current understanding of the etiology of pediatric cardiovascular disorders is limited.

Read full original descriptionShow less

The Congenital Heart Disease GEnetic NEtwork Study (CHD GENES) is a multi-center, prospective observational cohort study. Participants will be recruited from the Pediatric Cardiac Genomics Consortium's (PCGC) centers of the NHLBI-sponsored Bench to Bassinet (B2B) Program. Biological specimens will be obtained for genetic analyses, and phenotype data will be collected by interview and from medical records. State-of-the-art genomic technologies will be used to identify common genetic causes of CHD and genetic modifiers of clinical outcome.

To accomplish this, the PCGC will develop and maintain a biorepository of specimens (DNA) and genetic data, along with detailed, phenotypic and clinical outcomes data in order to investigate relationships between genetic factors and phenotypic and clinical outcomes in congenital heart disease.

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
30 January 2026